Hangzhou, China

Hao Duan

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Hangzhou Hyperchain Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hao Duan. Retrieved from https://idiyas.com/inventor/hao-duan-cs4wmgq3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hao Duan

Introduction

Hao Duan is an emerging inventor based in Hangzhou, China. He is currently associated with Hangzhou Hyperchain Technology Co., Ltd. Despite having no patents to his name yet, his contributions to the field of technology are noteworthy.

Latest Patents

As of now, Hao Duan has not registered any patents. However, his work at Hangzhou Hyperchain Technology Co., Ltd. indicates a potential for future innovations.

Career Highlights

Hao Duan has made significant strides in his career at Hangzhou Hyperchain Technology Co., Ltd. His role involves collaborating with talented individuals, which enhances the innovative environment of the company.

Collaborations

Hao Duan works alongside notable colleagues such as Weiwei Qiu and Wei Li. Their combined expertise fosters a creative atmosphere that is conducive to technological advancements.

Conclusion

Hao Duan is a promising inventor in the technology sector, and his future contributions may lead to significant innovations. His current position at Hangzhou Hyperchain Technology Co., Ltd. places him in a dynamic environment that encourages growth and creativity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…